Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Roche pushes to kick-start lung therapy Esbriet after big writedown
Roche pushes to kick-start lung therapy Esbriet after big writedown
ZURICH (Reuters) - Roche has won U.
FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma
FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma
Today, the U.
FDA Approves First Generic of Daraprim
FDA Approves First Generic of Daraprim
The U.
Two new medicines recommended for approval
Two new medicines recommended for approval
EMA’s human medicines committee (CHMP) recommended two medicines for approval at its February 2020 meeting.
Gilead to Acquire Forty Seven for $4.9 Billion
Gilead to Acquire Forty Seven for $4.9 Billion
FOSTER CITY, Calif.
GlaxoSmithKline reportedly looking to sell select antibiotic brands
GlaxoSmithKline reportedly looking to sell select antibiotic brands
Sale would fund R&D efforts in other key focus areas such as oncology.
BIOGEN and SANGAMO announced global licensing collaboration agreement
BIOGEN and SANGAMO announced global licensing collaboration agreement
CAMBRIDGE, Mass.
Merck and AMCM / EOS Cooperate in 3D Printing of Tablets
Merck and AMCM / EOS Cooperate in 3D Printing of Tablets
Merck, a leading science and technology company and AMCM, Starnberg, Germany, today announced a cooperation agreement on the 3D printing of tablets.
FUJIFILM Diosynth Biotechnologies expands North Carolina Facility
FUJIFILM Diosynth Biotechnologies expands North Carolina Facility
MORRISVILLE, N.
Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease
Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease
Osaka, Japan, February 26, 2020–Takeda Pharmaceutical Company Limited (TSE.
STADA becomes a major Consumer Healthcare player by acquiring 15 well-established GSK brands
STADA becomes a major Consumer Healthcare player by acquiring 15 well-established GSK brands
Bad Vilbel, February 24, 2020 – STADA AG is significantly expanding its global OTC business agreeing to acquire a portfolio of well-established local and regional consumer healthcare brands from Gla...
U.S. Health Secretary Says at Least 40 Labs Can Currently Test for Coronavirus
U.S. Health Secretary Says at Least 40 Labs Can Currently Test for Coronavirus
U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand